{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:00:25Z","timestamp":1793520025923,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1016\/j.ymgme.2003.08.022","type":"journal-article","created":{"date-parts":[[2003,10,9]],"date-time":"2003-10-09T04:37:07Z","timestamp":1065674227000},"page":"159-169","source":"Crossref","is-referenced-by-count":192,"title":["Enzyme replacement therapy in the mouse model of Pompe disease"],"prefix":"10.1016","volume":"80","author":[{"given":"N","family":"Raben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Danon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.L","family":"Thurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J","family":"Mattaliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.H","family":"Plotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2003.08.022_BIB1","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency \u2013 macrophage-targeted glucocerebrosidase for Gaucher\u2019s disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB2","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nrg963","article-title":"Enzyme replacement and enhancement therapies: lessons from lysosomal disorders","volume":"3","author":"Desnick","year":"2002","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1517\/13543784.11.5.675","article-title":"Enzyme replacement therapy for the mucopolysaccharide storage disorders","volume":"11","author":"Kakkis","year":"2002","journal-title":"Expert. Opin. Investig. Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.ymgme.2003.08.022_BIB4","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1007\/BF02680006","article-title":"Enzyme therapy for Pompe disease: from science to industrial enterprise","volume":"161","author":"Reuser","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/bj0860011","article-title":"Alpha-glucosidase deficiency in generalize glycogen storage disease (Pompe\u2019s disease)","volume":"86","author":"Hers","year":"1963","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB6","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3389","article-title":"Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency","author":"Hirschhorn","year":"2000"},{"key":"10.1016\/j.ymgme.2003.08.022_BIB7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1566524024605789","article-title":"Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease)","volume":"2","author":"Raben","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1067\/mpd.2000.107112","article-title":"Identification of two subtypes of infantile acid maltase deficiency","volume":"137","author":"Slonim","year":"2000","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB9","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0021-9258(18)34905-6","article-title":"Enhanced macrophage uptake of synthetically glycosylated human placental beta-glucocerebrosidase","volume":"257","author":"Doebber","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.bi.60.070191.001353","article-title":"Lysosomal storage diseases (Review)","volume":"60","author":"Neufeld","year":"1991","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB12","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.1016\/S0021-9258(18)63825-6","article-title":"Mannose 6-phosphate receptors and lysosomal enzyme targeting","volume":"264","author":"Dahms","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.bi.61.070192.001515","article-title":"Structure and function of the mannose 6-phosphate\/insulinlike growth factor II receptors","volume":"61","author":"Kornfeld","year":"1992","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB14","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/j.1460-2075.1988.tb02998.x","article-title":"Primary structure and processing of lysosomal alpha-glucosidase; homology with the intestinal sucrase-isomaltase complex","volume":"7","author":"Hoefsloot","year":"1988","journal-title":"EMBO J."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/bj2720485","article-title":"Expression and routeing of human lysosomal alpha-glucosidase in transiently transfected mammalian cells","volume":"272","author":"Hoefsloot","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB16","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0021-9258(18)53985-5","article-title":"Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation","volume":"268","author":"Wisselaar","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB17","first-page":"613","article-title":"Purification of recombinant human precursor acid alpha-glucosidase","volume":"43","author":"Van Hove","year":"1997","journal-title":"Biochem. Mol. Biol. Int."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1073\/pnas.93.1.65","article-title":"High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease","volume":"93","author":"Hove","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2003.08.022_BIB19","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/hmg\/7.11.1815","article-title":"Recombinant human acid alpha-glucosidase: high level production in mouse milk, biochemical characteristics, correction of enzyme deficiency in GSDII KO mice","volume":"7","author":"Bijvoet","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","article-title":"Recombinant human alpha-glucosidase from rabbit milk in Pompe patients","volume":"356","author":"Van den Hout","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2003.08.022_BIB21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1023\/A:1010383421286","article-title":"Enzyme therapy for Pompe disease with recombinant human alpha-glucosidase from rabbit milk","volume":"24","author":"Van den Hout","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00125817-200103000-00008","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mus.10381","article-title":"Morphological changes in muscle tissue of patients with infantile Pompe\u2019s disease receiving enzyme replacement therapy","volume":"27","author":"Winkel","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2003.08.022_BIB24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1172\/JCI1722","article-title":"Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail","volume":"101","author":"Kikuchi","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1357-4310(00)01694-4","article-title":"Towards a molecular therapy for glycogen storage disease type II (Pompe disease)","volume":"6","author":"Chen","year":"2000","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.ymgme.2003.08.022_BIB26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0925-4439(97)00092-6","article-title":"Molecular cloning of acid alpha-glucosidase cDNA of Japanese quail (Coturnix coturnix japonica) and the lack of its mRNA in acid maltase deficient quails","volume":"1362","author":"Kunita","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2003.08.022_BIB27","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/7.1.53","article-title":"Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease","volume":"7","author":"Bijvoet","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1022998010833","article-title":"Induction of tolerance to a recombinant human enzyme, acid alpha-glucosidase, in enzyme deficient knockout mice","volume":"12","author":"Raben","year":"2003","journal-title":"Transgen. Res."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB30","first-page":"132","article-title":"Biochemical, immunological, and cell genetic studies in glycogenosis type II","volume":"30","author":"Reuser","year":"1978","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB31","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/WNL.56.12.1739","article-title":"Surprises of genetic engineering: a possible model of polyglucosan body disease","volume":"56","author":"Raben","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2003.08.022_BIB32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-4157(95)00004-B","article-title":"Mannose 6-phosphate receptors in sorting and transport of lysosomal enzymes","volume":"1241","author":"Hille-Rehfeld","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2003.08.022_BIB33","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1073\/pnas.96.16.8861","article-title":"Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase","volume":"96","author":"Amalfitano","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2003.08.022_BIB34","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1006\/bbrc.2000.3555","article-title":"Correction of glycogen storage disease type II by enzyme replacement with a recombinant human acid maltase produced by over-expression in a CHO-DHFR(neg) cell line","volume":"276","author":"Martiniuk","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/104303401300042447","article-title":"Intercellular transfer of the virally derived precursor form of acid alpha-glucosidase corrects the enzyme deficiency in inherited cardioskeletal myopathy Pompe disease","volume":"12","author":"Pauly","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB36","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1089\/104303401750195917","article-title":"Long-term efficacy after [E1\u2212, polymerase\u2212] adenovirus-mediated transfer of human acid-alpha-glucosidase gene into glycogen storage disease type II knockout mice","volume":"12","author":"Ding","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB37","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1006\/mthe.2002.0563","article-title":"Efficacy of gene therapy for a prototypical lysosomal storage disease (GSD-II) is critically dependent on vector dose, transgene promoter, and the tissues targeted for vector transduction","volume":"5","author":"Ding","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB38","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/mthe.2002.0580","article-title":"Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors","volume":"5","author":"Fraites","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB39","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/hmg\/11.14.1637","article-title":"Muscle as a putative producer of acid alpha-glucosidase for glycogenosis type II gene therapy","volume":"11","author":"Martin-Touaux","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1525-0016(02)00055-2","article-title":"Long-term correction of glycogen storage disease type II with a hybrid Ad-AAV vector","volume":"7","author":"Sun","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB41","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1525-0016(02)90716-1","article-title":"Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme","volume":"6","author":"Raben","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0167-4889(98)00057-3","article-title":"Protein transport from the secretory to the endocytic pathway in mammalian cells","volume":"1404","author":"Le Borgne","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2003.08.022_BIB43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1210\/jc.75.2.424","article-title":"Expression of the insulin-like growth factor-II\/mannose-6-phosphate receptor in multiple human tissues during fetal life and early infancy","volume":"75","author":"Funk","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB44","first-page":"723","article-title":"Quantitation of Mr 46000 and Mr 300000 mannose 6-phosphate receptors in human cells and tissues","volume":"23","author":"Wenk","year":"1991","journal-title":"Biochem. Int."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB45","doi-asserted-by":"crossref","first-page":"16733","DOI":"10.1016\/S0021-9258(19)84766-X","article-title":"Developmental expression of the tissue insulin-like growth factor II\/mannose 6-phosphate receptor in the rat. Measurement by quantitative immunoblotting","volume":"264","author":"Sklar","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB46","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/hmg\/8.12.2145","article-title":"Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II","volume":"8","author":"Bijvoet","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB47","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/bmme.1996.0044","article-title":"Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I","volume":"58","author":"Kakkis","year":"1996","journal-title":"Biochem. Mol. Med."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/316953","article-title":"Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice","volume":"68","author":"Ioannou","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/bj1630193","article-title":"The influence of lysosomes on glycogen metabolism","volume":"163","author":"Geddes","year":"1977","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2003.08.022_BIB50","series-title":"Myology","first-page":"966","article-title":"Ultrastructural changes in diseased muscle","author":"Engel","year":"1994"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719203001732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719203001732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T19:16:29Z","timestamp":1623438989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719203001732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":50,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["S1096719203001732"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2003.08.022","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}